HORMONE-DEPENDENT PROSTATE CANCER

This adverse event was reported 70 times

These drugs are most commonly taken by patients reporting HORMONE-DEPENDENT PROSTATE CANCER:

# Drug Count
0 ABIRATERONE ACETATE 21
1 DOCETAXEL 20
2 DOCETAXEL ANHYDROUS 20
3 ABIRATERONE 19
4 DAROLUTAMIDE 17
5 BICALUTAMIDE 11
6 CARVEDILOL 10
7 LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN 10
8 PANTOPRAZOLE 10
9 ACETAMINOPHEN 9
See all common drugs associated with HORMONE-DEPENDENT PROSTATE CANCER

HORMONE-DEPENDENT PROSTATE CANCER is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 GALLIUM GA-68 GOZETOTIDE 5 0.0245
1 HYDROCHLORIC ACID 1 0.0045
2 TRIPTORELIN PAMOATE 6 0.0023
3 DEGARELIX 8 0.0015
4 DOLUTEGRAVIR SODIUM AND LAMIVUDINE 5 0.0014
5 LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN 10 0.0007
6 BICALUTAMIDE 11 0.0007
7 TRIPTORELIN 2 0.0006
8 DOLUTEGRAVIR SODIUM 5 0.0006
9 ABIRATERONE ACETATE 21 0.0005
See all drugs enriched for association with HORMONE-DEPENDENT PROSTATE CANCER